We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$576B
AUM Growth
+$48.6B
Cap. Flow
-$29.1B
Cap. Flow %
-5.06%
Top 10 Hldgs %
27.06%
Holding
15,819
New
1,459
Increased
5,619
Reduced
5,141
Closed
3,524

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$820M
2
MSFT icon
Microsoft
MSFT
+$811M
3
MCD icon
McDonald's
MCD
+$804M
4
KO icon
Coca-Cola
KO
+$655M
5
AMZN icon
Amazon
AMZN
+$646M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.64B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.1B
3
MSTR icon
Strategy Inc
MSTR
+$564M
4
KR icon
Kroger
KR
+$558M
5
DHR icon
Danaher
DHR
+$494M

Sector Composition

Rank Sector Weight
1 Technology 3.33%
2 Healthcare 3.23%
3 Consumer Discretionary 2.55%
4 Financials 2.55%
5 Industrials 1.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVK
12451
Advent Convertible and Income Fund
AVK
$573M
-19,121
Closed -$220K
AVNS
12452
CALL
DELISTED
Avanos Medical
AVNS
-3,500
Closed -$50.2K
AVNT icon
12453
CALL
Avient
AVNT
$4.25B
-2,300
Closed -$85.5K
AVNW icon
12454
PUT
Aviat Networks
AVNW
$287M
-8,500
Closed -$163K
AVO icon
12455
PUT
Mission Produce
AVO
$1.15B
-2,300
Closed -$24.1K
AVPT icon
12456
AvePoint
AVPT
$2.85B
-256,572
Closed -$4.45M
AVSF icon
12457
Avantis Short-Term Fixed Income ETF
AVSF
$654M
-68,206
Closed -$3.19M
JBIO
12458
CALL
Jade Biosciences
JBIO
$1.57B
-66
Closed -$5.77K
JBIO
12459
Jade Biosciences
JBIO
$1.57B
-899
Closed -$79K
JBIO
12460
PUT
Jade Biosciences
JBIO
$1.57B
-131
Closed -$11.5K
AVUS icon
12461
CALL
Avantis US Equity ETF
AVUS
$14.5B
-1,400
Closed -$129K
AVUS icon
12462
PUT
Avantis US Equity ETF
AVUS
$14.5B
-100
Closed -$9.24K
AVSU icon
12463
Avantis Responsible US Equity ETF
AVSU
$491M
-14,783
Closed -$922K
AWR icon
12464
PUT
American States Water
AWR
$3.53B
-9,800
Closed -$771K
AWRE icon
12465
CALL
Aware
AWRE
$26.4M
-43,900
Closed -$69.4K
AWRE icon
12466
Aware
AWRE
$26.4M
-30,051
Closed -$47.5K
AWRE icon
12467
PUT
Aware
AWRE
$26.4M
-100
Closed -$158
AXDX
12468
CALL
DELISTED
Accelerate Diagnostics
AXDX
-10,200
Closed -$7.15K
AXDX
12469
DELISTED
Accelerate Diagnostics
AXDX
-23,451
Closed -$16.4K
AXDX
12470
PUT
DELISTED
Accelerate Diagnostics
AXDX
-200
Closed -$140
AXGN icon
12471
Axogen
AXGN
$2.62B
-204,105
Closed -$2.67M
AXGN icon
12472
PUT
Axogen
AXGN
$2.62B
-13,400
Closed -$248K
AXR icon
12473
AMREP Corp
AXR
$119M
-15,820
Closed -$317K
AXTI icon
12474
PUT
AXT Inc
AXTI
$5.35B
-4,600
Closed -$6.49K
AYTU icon
12475
AYTU BioPharma
AYTU
$25.5M
-30,493
Closed -$36.6K

Similar funds

Citadel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Citadel Advisors held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Walmart Inc worth $401M.

  • Citadel Advisors's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
  • Citadel Advisors added most to NVIDIA in Q2 2025, an estimated $820M increase.
  • Citadel Advisors's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
  • Citadel Advisors fully exited Kroger in Q2 2025, selling an estimated $558M.
  • Citadel Advisors's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
  • Citadel Advisors opened 1,459 new positions and closed 3,524 in Q2 2025.
  • Citadel Advisors's portfolio value rose 9.2% quarter-over-quarter to $576B.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.